- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3 Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumab as Open-label Intravenous Induction Treatment Followed by Randomized Double-blind Subcutaneous Ustekinumab Maintenance in Pediatric Participants with Moderately to Severely Active Ulcerative Colitis
This study is looking at a medicine called ustekinumab (Stelara) for children and teenagers with a gut condition called ulcerative colitis. It hopes to see if it's safe and effective in helping them feel better and stay well, compared to a dummy medicine.
For: Moderately to Severely Active Ulcerative ColitisGermany · Hungary · Belgium - RecruitingPHASE3
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa
This study is testing a new medicine, remibrutinib, for people aged 12 and over with moderate to severe hidradenitis suppurativa (HS). Researchers want to see if it's safe and effective compared to a dummy pill.
For: Hidradenitis SuppurativaUnited States · Argentina · Austria